For chronic pain diseases to empower people by embedding AI in mobile phones and analysing in record time health data.


Healint Platform and Solutions

The global community has recorded over 300,000,000 health events on our platform. Our data scientists use that wealth of information to deliver technology and solutions that improve the lives of the one billion people living with chronic pain conditions. Learn more about our platform and services for patients and health service providers today.


Migraine Buddy

With over 1 million registered users, Migraine Buddy is the #1 migraine app in the world. Track your migraine, understand your triggers, and share your migraine history with your doctor to get the best possible treatment.


Making a Difference

Healint’s technology empowers patients, doctors, and researchers alike. Learn more about how we can help you.



Migraine Buddy can help you track and understand your migraines. Join the community that cares.



Our services help you provide better care to people who suffer from migraines.



Healint’s terabytes of real-world data power innovative research in the neurology field.


Latest  news


Healint Appoints Pharma Industry Veteran Maryline Marquet as Chief Commercial Officer

A series of senior hires underpins Healint’s strong global growth in predictive health analytics

Press Release - October 4th, 2018

Novartis Switzerland launches a pilot program with its employees including a custom version of the Migraine Buddy program from Healint

According to Danny Bar-Zohar, the global head of neuroscience development at Novartis, real-world experience is valuable for helping migraine sufferers with daily challenges.

Fierce Pharma - July 25th, 2018

Novartis, Healint study uses self tracking app to examine migraine, mental health connection. The research found that chronic migraines may induce anxiety and depression

Healint’s unique real-world evidence suggests, however, that anxiety and depression may result from migraine, not the other way around. 

MobiHealthNews - August 30th, 2018